For example, IL-17F is involved in mucosal host defence; IL-17E was confirmed to be an amplifier of TH2 immune responses, and IL-17A shows the highest involvement in tumour progression (including CRC), as well as inflammation and autoimmunity 128. This evidence concerns the gene IL17F and neoplasm.